Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Biochemia Medica
|
December 16, 2025
Effect sizes for nonparametric tests
Fernanda Fiel Peres
Schizophrenia Research
|
June 25, 2016
Peripubertal exposure to environmental enrichment prevents schizophrenia-like behaviors in the SHR strain animal model
Camila Mauricio Santos, Fernanda Fiel Peres, Mariana Cepollaro Diana, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
April 7, 2018
A schizophrenia-like behavioral trait in the SHR model: Applying confirmatory factor analysis as a new statistical tool
Fernanda Fiel Peres, Raí Álvares Eufrásio, Douglas Albuquerque Gouvêa, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
November 7, 2012
Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test
Valéria Almeida, Raquel Levin, Fernanda Fiel Peres, et al.
Frontiers in Pharmacology
|
February 22, 2021
Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
Cássio Morais Loss, Lucas Teodoro, Gabriela Doná Rodrigues, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
December 1, 2018
Young spontaneously hypertensive rats (SHRs) display prodromal schizophrenia-like behavioral abnormalities
Suzy Tamie Niigaki, Fernanda Fiel Peres, Lizia Ferreira, et al.
Neuropharmacology
|
May 20, 2019
Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit
Valéria Almeida, Raquel Levin, Fernanda Fiel Peres, et al.
Current Pharmaceutical Design
|
June 22, 2012
Antipsychotic profile of cannabidiol and rimonabant in an animal model of emotional context processing in schizophrenia
Raquel Levin, Valeria Almeida, Fernanda Fiel Peres, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Biochemia Medica
|
December 16, 2025
Effect sizes for nonparametric tests
Fernanda Fiel Peres
Schizophrenia Research
|
June 25, 2016
Peripubertal exposure to environmental enrichment prevents schizophrenia-like behaviors in the SHR strain animal model
Camila Mauricio Santos, Fernanda Fiel Peres, Mariana Cepollaro Diana, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
April 7, 2018
A schizophrenia-like behavioral trait in the SHR model: Applying confirmatory factor analysis as a new statistical tool
Fernanda Fiel Peres, Raí Álvares Eufrásio, Douglas Albuquerque Gouvêa, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
November 7, 2012
Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test
Valéria Almeida, Raquel Levin, Fernanda Fiel Peres, et al.
Frontiers in Pharmacology
|
February 22, 2021
Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
Cássio Morais Loss, Lucas Teodoro, Gabriela Doná Rodrigues, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
December 1, 2018
Young spontaneously hypertensive rats (SHRs) display prodromal schizophrenia-like behavioral abnormalities
Suzy Tamie Niigaki, Fernanda Fiel Peres, Lizia Ferreira, et al.
Neuropharmacology
|
May 20, 2019
Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit
Valéria Almeida, Raquel Levin, Fernanda Fiel Peres, et al.
Current Pharmaceutical Design
|
June 22, 2012
Antipsychotic profile of cannabidiol and rimonabant in an animal model of emotional context processing in schizophrenia
Raquel Levin, Valeria Almeida, Fernanda Fiel Peres, et al.
Page
of 1